Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying druggable disease-modifying gene products.

Current opinion in chemical biology - 1 Dec 2009

Dixon Scott J, Stockwell Brent R

Abstract excerpt

Many disease genes encode proteins that are difficult to target directly using small molecule drugs. Improvements in libraries based on synthetic compounds, natural products, and other types of molecules may ultimately allow some challenging proteins to be successfully targeted; however, these de...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease
Share to Drug Therapy
Share to Genome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmaceutical Preparations

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 19740696
DOI: 10.1016/j.cbpa.2009.08.003
PMCID: PMC2787993

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19740696-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying druggable disease-modifying gene products.PMID 19740696Read ↗

Drug discovery and development for rare genetic disordersSemantic proximity Read ↗

Chemical genetics: elucidating biological systems with small-molecule compounds.Semantic proximity Read ↗

Applying the logic of genetic interaction to discover small molecules that functionally interact with human disease alleles.Semantic proximity Read ↗

Development of Targeted Therapies Based on Gene Modification.Semantic proximity Read ↗

Pathway and network-based strategies to translate genetic discoveries into effective therapiesSemantic proximity Read ↗

High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need.Semantic proximity Read ↗

Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.Semantic proximity Read ↗

Identification of disease genes.Semantic proximity Read ↗

Small-Molecule Screening for Genetic DiseasesSemantic proximity Read ↗

Uncovering targets and molecular pathways for personalizing treatment in epilepsy.Semantic proximity Read ↗

Prevalent mouse phenotypes in the unexplored druggable genomeSemantic proximity Read ↗

Development of orphan drugs for rare diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.